{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:28:17Z","timestamp":1790681297792,"version":"4.1.0"},"reference-count":48,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Proprotein convertase subtilisin kexin 9 (PCSK9) increases LDL cholesterol (C) concentration by accelerating the hepatic degradation of the LDL receptor (R) thus promoting atherogenesis. The molecule, however, also exerts proinflammatory effects independent of circulating LDL-C by enhancing local cytokine production and activation of NFkB, a process that might involve Toll-like receptor 4 (TLR4), a crucial component of the innate immunity system. Tissue factor (TF), a glycoprotein which plays an essential role in coagulation and inflammation, is rapidly induced by circulating monocytes stimulated by proinflammatory agents through NFkB-dependent mechanisms. The aims of our study were (1) to assess whether PCSK9 may induce monocytic TF expression and (2) to evaluate whether the TLR4\/NFkB signaling pathway may contribute to that effect. Experiments were carried out in peripheral blood mononuclear cells (PBMCs), THP-1 cells, and HEK293 cells transfected with plasmids encoding the human TLR4 complex. PCSK9 increased procoagulant activity (PCA), mRNA and TF protein expression in both PBMCs and THP-1 cultures. Pre-treatment with inhibitors of TLR4\/NFkB signaling such as LPS-RS, CLI-095, and BAY 11-7082, downregulated PCSK9-induced TF expression. A similar effect was obtained by incubating cell cultures with anti-PCSK9 human monoclonal antibody. In TLR4-HEK293 cells, PCSK9 activated the TLR4\/NFkB signaling pathway to an extent comparable to LPS, the specific agonist of TLR4s and quantitative confocal microscopy documented the colocalization of PCSK9 and TLR4s. In conclusion, PCSK9 induces TF expression through activation of TLR4\/NFkB signaling.<\/jats:p>","DOI":"10.3390\/ijms222312640","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T04:48:37Z","timestamp":1638247717000},"page":"12640","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["PCSK9 Induces Tissue Factor Expression by Activation of TLR4\/NFkB Signaling"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2377-1161","authenticated-orcid":false,"given":"Valentina","family":"Scalise","sequence":"first","affiliation":[{"name":"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell\u2019Area Critica, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9760-8180","authenticated-orcid":false,"given":"Chiara","family":"Sanguinetti","sequence":"additional","affiliation":[{"name":"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell\u2019Area Critica, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7289-1522","authenticated-orcid":false,"given":"Tommaso","family":"Neri","sequence":"additional","affiliation":[{"name":"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell\u2019Area Critica, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Cianchetti","sequence":"additional","affiliation":[{"name":"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell\u2019Area Critica, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-123X","authenticated-orcid":false,"given":"Michele","family":"Lai","sequence":"additional","affiliation":[{"name":"Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Carnicelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell\u2019Area Critica, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1364-9568","authenticated-orcid":false,"given":"Alessandro","family":"Celi","sequence":"additional","affiliation":[{"name":"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell\u2019Area Critica, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7745-3890","authenticated-orcid":false,"given":"Roberto","family":"Pedrinelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell\u2019Area Critica, Universit\u00e0 di Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.acvd.2013.10.007","article-title":"PCSK9: From discovery to therapeutic applications","volume":"107","author":"Farnier","year":"2014","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Chapman","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/eurheartj\/ehx450","article-title":"Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: An analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration","volume":"39","author":"Ference","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ehjcvp\/pvz022","article-title":"PCSK9 and inflammation: A review of experimental and clinical evidence","volume":"5","author":"Gotto","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: Players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2017.04.023","article-title":"New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4\/NF-\u03baB pathway","volume":"262","author":"Tang","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_7","first-page":"cvaa254","article-title":"PCSK9 and LRP5 in macrophage lipid internalization and inflammation","volume":"29","author":"Badimon","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/kjm2.12225","article-title":"Inhibition of proprotein convertase subtilisin\/kexin type 9 attenuates 2,4,6-trinitrobenzenesulfonic acid-induced colitis via repressing toll-like receptor 4\/nuclear factor-kappa B","volume":"36","author":"Lei","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/cvr\/cvz262","article-title":"Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines","volume":"116","author":"Liu","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: Past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH09-11-0771","article-title":"Tissue factor and thrombosis: The clot starts here","volume":"104","author":"Owens","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(95)00209-X","article-title":"Cell biology of tissue factor, the principal initiator of blood coagulation","volume":"81","author":"Camerer","year":"1996","journal-title":"Thromb. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tcm.2015.12.001","article-title":"Tissue factor as a link between inflammation and coagulation","volume":"26","author":"Witkowski","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI8541","article-title":"Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide","volume":"105","author":"Lien","year":"2000","journal-title":"J. Clin. Invest."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.leukres.2005.05.004","article-title":"Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines","volume":"29","author":"Alaniz","year":"2005","journal-title":"Leuk. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: Structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Tuakli-Wosornu, Y., Lagace, T.A., Kinch, L., Grishin, N.V., Horton, J.D., Cohen, J.C., and Hobbs, H.H. (2006). Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am. J. Hum. Genetics, 514\u2013523.","DOI":"10.1086\/507488"},{"key":"ref_21","first-page":"S9","article-title":"Tissue factor expression by monocytes: Regulation and pathophysiological roles","volume":"9","author":"Osterud","year":"1998","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1160\/TH04-12-0845","article-title":"A subpopulation of human B lymphocytes can express a functional Tissue Factor in response to phorbol myristate acetate","volume":"94","author":"Mechiche","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-0035-1564041","article-title":"The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease: Insights into Platelet Tissue Factor","volume":"41","author":"Camera","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/jcm.27.5.947-951.1989","article-title":"Single-step, chromogenic Limulus amebocyte lysate assay for endotoxin","volume":"27","author":"Lindsay","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41598-018-20425-x","article-title":"PCSK9 induces a pro-inflammatory response in macrophages","volume":"8","author":"Ricci","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1194\/jlr.M011445","article-title":"A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo","volume":"52","author":"Ni","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1242\/jcs.1988.Supplement_9.7","article-title":"Macrophage lipoprotein receptors","volume":"9","author":"Fogelman","year":"1988","journal-title":"J. Cell. Sci. Suppl."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/path.4630","article-title":"Local effects of human PCSK9 on the atherosclerotic lesion","volume":"238","author":"Giunzioni","year":"2016","journal-title":"J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0038-1676863","article-title":"PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention","volume":"119","author":"Paciullo","year":"2019","journal-title":"Thromb. Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/SHK.0000000000000682","article-title":"Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis","volume":"46","author":"Dwivedi","year":"2016","journal-title":"Shock"},{"key":"ref_31","first-page":"7","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice","volume":"30","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ochoa, E., Iriondo, M., Manzano, C., Fullaondo, A., Villar, I., Ruiz-Irastorza, G., Zubiaga, A.M., and Estonba, A. (2016). LDLR and PCSK9 are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146990"},{"key":"ref_33","first-page":"312","article-title":"Positive correlation between plasma PCSK9 and tissue factors levels in patients with angiographically diagnosed coronary artery disease and diabetes mellitus","volume":"13","author":"Wang","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000442976","article-title":"Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis","volume":"8","author":"Boyd","year":"2016","journal-title":"J. Innate Immun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40560-016-0149-0","article-title":"Sepsis and disseminated intravascular coagulation","volume":"4","author":"Okamoto","year":"2016","journal-title":"J. Intensive Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.21037\/atm.2016.08.53","article-title":"THP-1 cells as a model for human monocytes","volume":"4","author":"Bosshart","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.numecd.2008.07.011","article-title":"Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients","volume":"19","author":"Wang","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1172\/JCI58969","article-title":"Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin","volume":"122","author":"Owens","year":"2012","journal-title":"J. Clin. Invest."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.0703402104","article-title":"The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain","volume":"11","author":"Hampton","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1582-4934.2009.00899.x","article-title":"Resistin competes with lipopolysaccharide for binding to toll-like receptor 4","volume":"14","author":"Tarkowski","year":"2010","journal-title":"J. Cell Mol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000318775","article-title":"Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-\u0138B-dependent pathway","volume":"48","author":"Cirillo","year":"2011","journal-title":"J. Vasc. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cmet.2014.01.013","article-title":"Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes","volume":"19","author":"Lee","year":"2014","journal-title":"Cell Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/eurheartj\/ehz566","article-title":"Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin\/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin\/kexin type-9","volume":"41","author":"Jang","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12950-016-0123-6","article-title":"The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells","volume":"13","author":"Balia","year":"2016","journal-title":"J. Inflamm. (Lond.)"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102269","DOI":"10.1101\/pdb.prot102269","article-title":"Bradford Assay for Determining Protein Concentration","volume":"2020","author":"Kielkopf","year":"2020","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1038\/s41598-021-90219-1","article-title":"Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin","volume":"11","author":"Lai","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1016\/j.biomaterials.2005.04.063","article-title":"Endotoxin: The uninvited guest","volume":"26","author":"Gorbet","year":"2005","journal-title":"Biomaterials"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12640\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:34:40Z","timestamp":1760168080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":48,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222312640"],"URL":"https:\/\/doi.org\/10.3390\/ijms222312640","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}